The clinical KRAS(G12C) inhibitor AMG 510 drives anti-tumour immunity - Jude Canon, Karen Rex, Anne Y. Saiki, Christopher Mohr, Keegan Cooke, Dhanashri Bagal, Kevin Gaida, Tyler Holt, Charles G. Knutson, Neelima Koppada, Brian A. Lanman, Jonathan Werner, Aaron S. Rapaport, Tisha San Miguel, Roberto Ortiz - Dissemin

Language
Login

Published in

Nature Research, Nature, 7781(575), p. 217-223, 2019

DOI: 10.1038/s41586-019-1694-1

Links

ORCID
Nature Research | PDF

Tools

Export citation

Search in Google Scholar

The clinical KRAS(G12C) inhibitor AMG 510 drives anti-tumour immunity

Journal article published in 2019 by Jude Canon, Karen Rex, Anne Y. Saiki, Christopher Mohr, Keegan Cooke, Dhanashri Bagal, Kevin Gaida, Tyler Holt, Charles G. Knutson, Neelima Koppada, Brian A. Lanman, Jonathan Werner, Aaron S. Rapaport, Tisha San Miguel, Roberto Ortiz and other authors.

This paper was not found in any repository, but could be made available legally by the author.

This paper was not found in any repository, but could be made available legally by the author.

Full text: Unavailable

Green circle

Preprint: archiving allowed

Upload

Orange circle

Postprint: archiving restricted

Upload

Red circle

Published version: archiving forbidden

Policy details

Data provided by

SHERPA/RoMEO